DHEA-S Blood Test: Meaning, Age and Clinical Context

The adrenal cortex makes DHEA, DHEA-S and other steroid precursors. DHEA can be converted to its sulfated form by an adrenal enzyme, while DHEA-S can be desulfated back to DHEA in tissues. DHEA is the unconjugated molecule; DHEA-S is its sulfate ester. They are related molecules measured by different tests, with different analytical behaviour and clinical questions.^{See reference 2,See reference 3}

DHEA-S itself has weak or limited direct androgen activity, but it sits in a circulating pool that can contribute to tissue production of more active androgens. It is present at higher and more stable concentrations than DHEA, which is why many clinical laboratories use DHEA-S as an indicator of adrenal androgen production.^{See reference 2}

The adrenal glands are the main source, but smaller amounts of DHEA-S can come from the ovaries or testes. A DHEA-S result therefore helps with source assessment, especially when androgen excess is suspected, but it is not a complete map of androgen production and does not replace testosterone, sex hormone-binding globulin, 17-hydroxyprogesterone or other tests selected for the clinical question.^{See reference 1,See reference 2}

The history around an androgen result is as important as the number. A clinician may ask when acne, excess hair, scalp hair loss, menstrual change, voice change or other features began, whether they are progressing, and whether they began after a medicine or supplement. Slow, mild features that began earlier can fit common patterns such as PCOS, while late or rapid onset and virilisation can point toward a less common cause.^{See reference 1,See reference 2}

For women with suspected androgen excess, the 2025 Society for Endocrinology guideline recommends a broader biochemical assessment, including testosterone, sex hormone-binding globulin, androstenedione, DHEA-S, 17-hydroxyprogesterone, oestradiol, luteinising hormone and follicle-stimulating hormone, with free testosterone assessed by a suitable method. It recommends morning sampling after an overnight fast where possible and method-aware follow-up when immunoassay results do not fit the clinical picture.^{See reference 2}

These are clinician-facing recommendations for evaluating androgen excess in women, not a self-ordering checklist. The appropriate tests, timing and urgency vary with age, pregnancy possibility, hormone therapy, symptoms and local practice.^{See reference 1,See reference 2}

Many DHEA-S tests do not require special preparation, but the right instructions depend on the other tests ordered and the clinical question. If the test is part of an androgen-excess assessment, ask whether morning collection, fasting or a particular point in the menstrual cycle is wanted. Do not change food, exercise, prescribed medicines or hormone therapy to manufacture a preferred result.^{See reference 1,See reference 2}

Before the draw, list prescription medicines, over-the-counter products, DHEA or testosterone products, hormone therapy, vitamins and supplements. The laboratory or clinician can tell you whether any temporary pause is appropriate for that method; do not stop a prescribed medicine without advice.^{See reference 1,See reference 3}

Biotin-containing products deserve specific mention because some immunoassays can be affected. Ask whether the laboratory's method requires any temporary preparation step; do not apply a universal pause.^{See reference 4}

When the report arrives, look first at the laboratory's own interval and method. Then ask how the result fits the symptoms, speed of change, age, sex, reproductive or hormone-treatment context and other results such as testosterone, sex hormone-binding globulin, 17-hydroxyprogesterone, cortisol or ACTH when clinically relevant. A clinician may choose observation, additional testing, method confirmation or imaging based on that complete pattern.^{See reference 1,See reference 2}

Useful questions include: What clinical question is this test answering? Is the result being compared with the correct age- and sex-specific interval? Which assay measured it, and has the method changed from an earlier test? Could medicines, hormone therapy or DHEA products affect it? Should it be interpreted with testosterone, sex hormone-binding globulin, 17-hydroxyprogesterone, cortisol, ACTH or other tests?^{See reference 1,See reference 2,See reference 5}

Could biotin affect the assay, and does the laboratory have method-specific preparation instructions?^{See reference 4}

If the result is high, ask what features would make the pattern more concerning, whether the change was rapid, and whether specialist review or imaging is appropriate. If it is low, ask whether age, glucocorticoids, pituitary or adrenal symptoms provide a plausible explanation and whether other adrenal testing is needed. These questions support a clinical assessment; they do not create a diagnosis from a single result.^{See reference 1,See reference 2,See reference 3}

This guide cannot diagnose PCOS, adrenal insufficiency, congenital adrenal hyperplasia or a tumour, and it cannot set a hormone dose. Bring the original report and a complete medicine and supplement list to a qualified healthcare professional.^{See reference 1,See reference 2,See reference 3}